1. Home
  2. NVRO vs DHF Comparison

NVRO vs DHF Comparison

Compare NVRO & DHF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NVRO
  • DHF
  • Stock Information
  • Founded
  • NVRO 2006
  • DHF 1998
  • Country
  • NVRO United States
  • DHF United States
  • Employees
  • NVRO N/A
  • DHF N/A
  • Industry
  • NVRO Medical/Dental Instruments
  • DHF Finance Companies
  • Sector
  • NVRO Health Care
  • DHF Finance
  • Exchange
  • NVRO Nasdaq
  • DHF Nasdaq
  • Market Cap
  • NVRO 214.2M
  • DHF 188.4M
  • IPO Year
  • NVRO 2014
  • DHF N/A
  • Fundamental
  • Price
  • NVRO $5.79
  • DHF $2.52
  • Analyst Decision
  • NVRO Hold
  • DHF
  • Analyst Count
  • NVRO 12
  • DHF 0
  • Target Price
  • NVRO $7.24
  • DHF N/A
  • AVG Volume (30 Days)
  • NVRO 1.1M
  • DHF 451.1K
  • Earning Date
  • NVRO 03-04-2025
  • DHF 01-01-0001
  • Dividend Yield
  • NVRO N/A
  • DHF 7.65%
  • EPS Growth
  • NVRO N/A
  • DHF N/A
  • EPS
  • NVRO N/A
  • DHF N/A
  • Revenue
  • NVRO $408,518,000.00
  • DHF N/A
  • Revenue This Year
  • NVRO $1.55
  • DHF N/A
  • Revenue Next Year
  • NVRO $4.36
  • DHF N/A
  • P/E Ratio
  • NVRO N/A
  • DHF N/A
  • Revenue Growth
  • NVRO N/A
  • DHF N/A
  • 52 Week Low
  • NVRO $3.17
  • DHF $2.06
  • 52 Week High
  • NVRO $14.70
  • DHF $2.39
  • Technical
  • Relative Strength Index (RSI)
  • NVRO 70.07
  • DHF 34.49
  • Support Level
  • NVRO $5.77
  • DHF $2.54
  • Resistance Level
  • NVRO $5.80
  • DHF $2.60
  • Average True Range (ATR)
  • NVRO 0.03
  • DHF 0.02
  • MACD
  • NVRO -0.04
  • DHF -0.01
  • Stochastic Oscillator
  • NVRO 70.00
  • DHF 0.00

About NVRO Nevro Corp.

Nevro Corp is a medical device company. Its key product is the HFX spinal cord stimulation (SCS) platform, which includes the Senza SCS system, an evidence-based neuromodulation system for the treatment of chronic pain. Senza generates electrical impulses to relieve pain. The system is implanted by physicians and controlled by patients. It consists of leads, a trial stimulator, an implantable pulse generator, surgical tools, a clinician laptop programmer, a patient remote control, and a mobile charger. The company generates the majority of its revenue in the United States.

About DHF BNY Mellon High Yield Strategies Fund

BNY Mellon High Yield Strategies Fund is a diversified, closed-end management investment company. The fund's primary investment objective is to seek high current income and its secondary objective is capital appreciation. It invests predominantly in fixed-income securities of below-investment-grade credit quality.

Share on Social Networks: